Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2334

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania ; volume:19 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
BMC infectious diseases ; 19, Heft 1 (7.2.2019), 1-6, 12.2019

Creator: Juma, Saumu Pazia
Maro, Athanasia
Pholwat, Suporn
Mpagama, Stellah G.
Gratz, Jean
Liyoyo, Alphonse
Houpt, Eric R.
Kibiki, Gibson S.
Mmbaga, Blandina T.
Heysell, Scott K.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-019-3757-1

URN: urn:nbn:de:101:1-2019031301005425318405

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Juma, Saumu Pazia
Maro, Athanasia
Pholwat, Suporn
Mpagama, Stellah G.
Gratz, Jean
Liyoyo, Alphonse
Houpt, Eric R.
Kibiki, Gibson S.
Mmbaga, Blandina T.
Heysell, Scott K.
SpringerLink (Online service)

Other Objects (12)

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to mathematically optimize drug regimens using optimal control

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Drugs : evaluations of drugs and drug therapy

Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient

Related objects

Reset password